1. Signaling Pathways
  2. Membrane Transporter/Ion Channel
  3. SLC39 (Zinc Transporter)

SLC39 (Zinc Transporter) 

Zinc Transporter

SLC39 是一个主要的锌转运蛋白家族,影响锌的吸收、分布和代谢,控制细胞内锌稳态。人类的 SLC39 转运蛋白由 14 个基因组编码,分为四个亚家族:亚家族 I 包括 ZIP9,介导高尔基体中的锌转运;亚家族 II 包括 ZIP1/2/3,将锌从细胞外或细胞器转运到细胞质中,调节锌的吸收;gufA 亚家族包括 ZIP11,LIV-1 亚家族包括 ZIP4/5/6/7/8/10/12/13/14,调节锌的吸收、转运和排泄,并与免疫系统功能、炎症反应、镉毒性和铁代谢有关。SLC39 功能障碍会导致神经退行性疾病、癌症、炎症、埃勒斯-丹洛斯综合征和哮喘[1]

SLC39 is a major zinc transporter family that affects the absorption, distribution and metabolism of zinc, controls intracellular zinc homeostasis. SLC39 transporters are encoded in human by 14 genome, which are divided into four subfamilies: subfamily I includes ZIP9 that mediates the zinc transport in the Golgi apparatus; subfamily II includes ZIP1/2/3 that transports zinc from the extracellular or organelles into the cytoplasm, regulates the zinc absorption; gufA subfamily includes ZIP11 and LIV-1 subfamily includes ZIP4/5/6/7/8/10/12/13/14 that regulate zinc absorption, transport and excretion, and are related to immune system function, inflammatory response, cadmium toxicity and iron metabolism. SLC39 dysfunction causes neurodegenerative disorders, cancer, inflammation, Ehlers-Danlos syndrome and asthma[1].

SLC39 (Zinc Transporter) 相关产品 (2):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-114395
    NVS-ZP7-4 98.85%
    NVS-ZP7-4 是锌转运体 SLC39A7/ZIP7 的抑制剂,能够指示内质网锌水平。ZIP7 是 Notch 通路中的一种活性分子节点,并调控铁死亡。NVS-ZP7-4 能够引起内质网应激,并发挥一定的铁死亡 (ferroptosis) 抑制作用,抑制 Erastin (HY-15763) 引起的细胞死亡。
    NVS-ZP7-4
  • HY-P991145
    Laventatug Inhibitor
    Laventatug 是一种人源化单克隆抗体,靶向人 SLC39A6。Laventatug 通过特异性结合 SLC39A6,干扰细胞内锌离子的转运过程,进而发挥抗肿瘤活性。Laventatug 有望用于癌症的研究。
    Laventatug